Serum prostate-specific antigen (PSA) screening is useful for early diagnosis of prostate cancer; however, PSA screening has many shortcomings, for example, PSA levels are often elevated in men suffering benign prostate inflammation. This evidence concerns the gene KLK3 and prostate cancer.